(SPYU) MAX S P 500 4X Leveraged ETN - Ratings and Ratios
Leveraged, Daily, Index, Notes
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 55.9% |
| Value at Risk 5%th | 96.4% |
| Relative Tail Risk | 4.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.32 |
| Alpha | -39.40 |
| CAGR/Max DD | 0.78 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.414 |
| Beta | 3.783 |
| Beta Downside | 3.863 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.27% |
| Mean DD | 12.08% |
| Median DD | 7.47% |
Description: SPYU MAX S P 500 4X Leveraged ETN October 26, 2025
The MAX S &P 500 4X Leveraged ETN (NYSE ARCA: SPYU) is a daily-reset trading instrument that seeks to deliver four times the long-day performance of the S&P 500 index, after deducting the Daily Investor Fee, Daily Financing Charge, and any applicable Redemption Fee. It is marketed to sophisticated investors as a short-term risk-management tool within a diversified portfolio, not a buy-and-hold vehicle.
Key quantitative points to consider: (1) SPYU’s expense ratio is 0.75% p.a., but the effective cost can exceed 1% p.a. when daily financing charges are included, especially in volatile markets; (2) Because of daily compounding, a 2% S&P 500 gain over 10 days does not translate to a 8% gain in SPYU-historical back-tests show a typical drag of 10-15% relative to the theoretical 4× return in trending markets; (3) Macro drivers such as Federal Reserve policy, earnings season strength, and sector rotation in large-cap growth versus value stocks heavily influence the underlying index, amplifying SPYU’s sensitivity to market swings.
If you want a data-driven, risk-adjusted performance snapshot of SPYU, a quick look at the analytics on ValueRay can help you gauge whether the instrument fits your short-term tactical strategy.
What is the price of SPYU shares?
Over the past week, the price has changed by -2.88%, over one month by -4.13%, over three months by +6.58% and over the past year by +2.90%.
Is SPYU a buy, sell or hold?
What are the forecasts/targets for the SPYU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 60.5 | 9.9% |
SPYU Fundamental Data Overview December 05, 2025
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 449.5m USD (449.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 449.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 449.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 19.96% (E(449.5m)/V(449.5m) * Re(19.96%) + (debt-free company))
Discount Rate = 19.96% (= CAPM, Blume Beta Adj.) -> capped to 17.95%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for SPYU ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle